Lynn Diana Feild

Array ( [id] => 6925871 [patent_doc_number] => 20050239126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Proteases' [patent_app_type] => utility [patent_app_number] => 11/167040 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44701 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239126.pdf [firstpage_image] =>[orig_patent_app_number] => 11167040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894008 [patent_doc_number] => 20080103107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Screening Methods' [patent_app_type] => utility [patent_app_number] => 11/630720 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15085 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103107.pdf [firstpage_image] =>[orig_patent_app_number] => 11630720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520863 [patent_doc_number] => 20090028844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'GALNTS AS MODIFIERS OF THE IGFR PATHWAY AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/628560 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15790 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028844.pdf [firstpage_image] =>[orig_patent_app_number] => 11628560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574911 [patent_doc_number] => 20090142272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Pfks as modifiers of the igfr pathway and methods of use' [patent_app_type] => utility [patent_app_number] => 11/628557 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16756 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142272.pdf [firstpage_image] =>[orig_patent_app_number] => 11628557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016195 [patent_doc_number] => 20070259404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Method of Producing Heterologous Proteases' [patent_app_type] => utility [patent_app_number] => 11/630314 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11062 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259404.pdf [firstpage_image] =>[orig_patent_app_number] => 11630314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880918 [patent_doc_number] => 20060030001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Useful polypeptides' [patent_app_type] => utility [patent_app_number] => 11/148280 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 41831 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030001.pdf [firstpage_image] =>[orig_patent_app_number] => 11148280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231312 [patent_doc_number] => 20070293420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method for Purifying Erythropoietin' [patent_app_type] => utility [patent_app_number] => 11/570224 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4561 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293420.pdf [firstpage_image] =>[orig_patent_app_number] => 11570224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631478 [patent_doc_number] => 20060147947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'AMPK pathway components' [patent_app_type] => utility [patent_app_number] => 11/145471 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50335 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147947.pdf [firstpage_image] =>[orig_patent_app_number] => 11145471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793499 [patent_doc_number] => 20060014180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Human phosphatase RET31, and variants thereof' [patent_app_type] => utility [patent_app_number] => 11/143984 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 241070 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014180.pdf [firstpage_image] =>[orig_patent_app_number] => 11143984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952186 [patent_doc_number] => 20050227280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Proteases' [patent_app_type] => utility [patent_app_number] => 11/140224 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43787 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227280.pdf [firstpage_image] =>[orig_patent_app_number] => 11140224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625283 [patent_doc_number] => 20060263788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Human kinase interacting protein 2 (KIP2)-related gene variant (KIP2V1) associated with prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/130952 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5913 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263788.pdf [firstpage_image] =>[orig_patent_app_number] => 11130952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472225 [patent_doc_number] => 07229787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Method of N-terminal cleavage using an aminopeptidase' [patent_app_type] => utility [patent_app_number] => 11/131035 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12165 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229787.pdf [firstpage_image] =>[orig_patent_app_number] => 11131035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7055584 [patent_doc_number] => 20050276757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Methods of using ZC1 and ZC3 kinase substrate phosphorylation as biomarkers' [patent_app_type] => utility [patent_app_number] => 11/128106 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11861 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20050276757.pdf [firstpage_image] =>[orig_patent_app_number] => 11128106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667028 [patent_doc_number] => 20060172378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Variants of protein kinases' [patent_app_type] => utility [patent_app_number] => 11/121133 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 138 [patent_figures_cnt] => 138 [patent_no_of_words] => 22012 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172378.pdf [firstpage_image] =>[orig_patent_app_number] => 11121133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533554 [patent_doc_number] => 07172887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Methods for producing citric acid using host cells deficient in oxaloacetate hydrolase' [patent_app_type] => utility [patent_app_number] => 11/122506 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13618 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/172/07172887.pdf [firstpage_image] =>[orig_patent_app_number] => 11122506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978537 [patent_doc_number] => 20050288255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Modulation of lysophosphatidylcholine and treatment of diet-induced conditions' [patent_app_type] => utility [patent_app_number] => 11/121705 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10593 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288255.pdf [firstpage_image] =>[orig_patent_app_number] => 11121705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771579 [patent_doc_number] => 20050267030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Use of deltaPKC peptides for modulation of reactive oxygen species' [patent_app_type] => utility [patent_app_number] => 11/119098 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8079 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267030.pdf [firstpage_image] =>[orig_patent_app_number] => 11119098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7247157 [patent_doc_number] => 20050272077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases' [patent_app_type] => utility [patent_app_number] => 11/111239 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13613 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272077.pdf [firstpage_image] =>[orig_patent_app_number] => 11111239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050744 [patent_doc_number] => 20050186631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Nematode PPPT-like sequences' [patent_app_type] => utility [patent_app_number] => 11/110578 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15864 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186631.pdf [firstpage_image] =>[orig_patent_app_number] => 11110578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056001 [patent_doc_number] => 20050277175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Truncated ADAMTS molecules' [patent_app_type] => utility [patent_app_number] => 11/109157 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15968 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277175.pdf [firstpage_image] =>[orig_patent_app_number] => 11109157 [rel_patent_id] =>[rel_patent_doc_number] =>)